Dronabinol is safe and effective for the treatment of Alzheimer disease with agitation (Agit-AD), according to a stu ...

This podcast episode examines two studies that assess the impact type 2 diabetes has on brain health and explores three ...

A research team comprising several researchers within the University of Kentucky's Sanders-Brown Center on Aging has ...

Staff, residents and family members at Station Court Care Home in Ashington have raised awareness and funds for their ...

An Alzheimer’s treatment from idea to market can take up to 20 years. After a long hiatus, the U.S. Food and Drug Administration (FDA) has approved three new drugs to treat Alzheimer’s since June 2021 ...

Indiana University School of Medicine researchers have identified a new genetic marker that could play a role in the ...

Now, research has found that higher levels of light pollution are associated with a greater prevalence of Alzheimer’s disease, the most common cause of dementia.

The five big factors increasing the risk for cognitive decline, dementia or both: diabetes, midlife hypertension or high ...

Researchers have found that the drug dronabinol — a synthetic version of the psychoactive THC compound in cannabis — helped ...

Scientists have developed a novel peptide that could potentially revolutionize the treatment of Alzheimer's disease and other neurodegenerative disorders known as tauopathies.

A study reveals that high cholesterol and blood sugar levels in your 30s and 40s could significantly increase your risk of ...

Walk for hope. Walk for a loved one. Walk for a cure. Late October, nearly a hundred participants across 19 teams in LaGrange ...